Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
so adding her name is nothing anybody cares about.
Squirrel!
You know very well that people get patents all the time in areas that were not their original academic or professional fields. Anyone of a degree of intelligence, who works in a field for a time, can gain sufficient expertise to contribute to an invention and LP has been associated with oncology for a long time. So this line of argument by you and LC is really nothing but a thinly veiled insult or desperation.
2005 - the year the Earth stood still and all knowledge stopped advancing.
My thoughts exactly.
144 (film), 2015 Indian Tamil film
LOL. Well done Sojo.
AF is adept at 'engineering' scenarios using snippets of real information to his advantage. Long time posters on this board will recall incident whem AF elicited a negative statement from an individual at MD Anderson who wasn't even involved on the DCVAX trial there. That is his MO to cause a negative market reaction to any development at a company he is opposing. AF is the 'dirty trickster' of biotechs.
No surprise, given what they are doing - basically running a con.
I have been thinking as well that something along those lines could unfold and allow the current NWBO to fully realize the potential of their solutions.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159637563
Isn't this capacity of 450 - 500 patients, without Flaskworks? I believe it would certainly go up significantly once they deploy Flaskworks.
You called it Sojo!
The stock price has been doing the penny dance for over an hour. Perhaps 'treading water' for a bit before progressing upwards.
If CRL wanted a significant position in nwbo, they could buy it in the open market without acquiring Cognate.
Agreed. Virginia, as a state, has good K - 12 public schools and this is especially true for Northern Virginia. Plus, the full complement of Virginia's public post-secondary institutions are pretty well regarded as well
Northern Virginia here and I can corroborate Bio's statement:
Same job, same pay for me and my friends, higher taxes
If these are jokers, why are you hanging around then?
Thanks for the response, Senti. Have always respected your opinion, including on whether we are hearing hoof beats or zebras.
Hi Senti,
You wrote:
Apparently there are some larger shareholders encouraging the company to disclose at the best and most opportune time, after all the details have been thoroughly vetted, and are fine with waiting.
Unless there is something in the 10Q that requires a PR and the PR then references the 10Q.
Ahh, forgot about that Q.
Was that a subtle Star Trek reference?
Sounds more and more as if they found a new way to sell tin foil hats at the expense of GBM patients. And making out like bandits doing so.
The bubbling is getting a bit more energetic.
Just a fun observation and of no significance - but the NWBO chart for 12/31/2020, heading into the New Year, looks like a smiley.
If a BO is relatively imminent, why would they need to push to remain compliant with Exchange standards? Or, they could give that as a reason to get an extension.
Hoe these words go from your keyboard to God's ears.
Sojo,
Many thanks for your excellent and insightful TA throughout this year as well. I looked forward to your charts for affirmation and to make sense of the SP variations and gyrations. The science, as explained by many other posters, has always been outstanding, but the charts helped in showing that the machinations of market forces were failing.
A very happy new year to you and I, as I am sure all the other NWBO longs on this board or otherwise, look forward to a brilliant 2021.
I believe FFS had anticipated some downward movements and volatility.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160470462
Perhaps she knows the party that is speculated to have taken a big position. If she trusts them, then perhaps published her article to encourage her clients and followers to invest as well.
Could be the same people who caused the October rally.
Perhaps that is why, as DI said, they are working every day, except Christmas, till the end of the year.
iwasadiver,
It is mu understanding from reading posts on the board that a filing a BLA and getting marketing approval is a lengthy process.
Is it quicker to get an EAP or EUA as an interim measure while the BLA process plays out and would any of those be applicable?
He can post all weekend. Those of us who are invested will be doing other things in our lives.
I know that some will say, the trial was too unorthodox
And an improved Quality of Life - something that DCVAX-L provides and facilitates.
BSB, You indicate that Company knew by October 19th. However, Dr. Lau was still blinded as of November 6. I would think the PI would be given the data at the same as the company. Thoughts?
Thanks for the response. Understood and agreed on this becoming a moot point, hopefully soon.
Hi ATLnsider. Thanks for putting together this valuable comparison.
Since NWBO TLD has not been released, the chart is comparing blinded, blended DCVAX-L data with unblinded official results of the other four trials. Presumably, the unblinded results are going to be significantly better.
As such it may be interesting to see what the blinded, blended data showed for these four trials. Could you post those, in case you happen to have them in hand?
That too.
Given the pattern today and if the last two days are an indication, someone will slam the SP down at the close.
Tryn2 - that does not make sense. Some of them may individually not have experience, but they have a Clinical Research Organization (CRO) conducting their trial who does, as well as Dr. Liau, Dr. Bosch, their SAB, etc., who surely have such experience and can advise.